259 related articles for article (PubMed ID: 35293845)
1. Atomic level and structural understanding of natural ligands inhibiting
Sunder Raj D; Kesavan DK; Kottaisamy CPD; Kumar VP; Hopper W; Sankaran U
J Biomol Struct Dyn; 2023 May; 41(8):3440-3461. PubMed ID: 35293845
[No Abstract] [Full Text] [Related]
2. Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation.
Cai J; Han C; Hu T; Zhang J; Wu D; Wang F; Liu Y; Ding J; Chen K; Yue J; Shen X; Jiang H
Protein Sci; 2006 Sep; 15(9):2071-81. PubMed ID: 16882991
[TBL] [Abstract][Full Text] [Related]
3. Identification of immucillin analogue natural compounds to inhibit
Raj DS; Kottaisamy CPD; Hopper W; Sankaran U
In Silico Pharmacol; 2021; 9(1):22. PubMed ID: 33786292
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of a new peptide deformylase from human pathogenic bacterium Helicobacter pylori.
Han C; Wang Q; Dong L; Sun H; Peng S; Chen J; Yang Y; Yue J; Shen X; Jiang H
Biochem Biophys Res Commun; 2004 Jul; 319(4):1292-8. PubMed ID: 15194508
[TBL] [Abstract][Full Text] [Related]
5. Molecular Docking and Dynamics Simulation Analysis of Thymoquinone and Thymol Compounds from
Tabassum H; Ahmad IZ
Med Chem; 2021; 17(2):146-157. PubMed ID: 32116195
[TBL] [Abstract][Full Text] [Related]
6. Identification of Helicobacter pylori-carcinogenic TNF-alpha-inducing protein inhibitors via daidzein derivatives through computational approaches.
Tayyeb JZ; Mondal S; Anisur Rahman M; Kumar S; Bayıl I; Akash S; Hossain MS; Alqahtani T; Zaki MEA; Oliveira JIN
J Cell Mol Med; 2024 May; 28(9):e18358. PubMed ID: 38693868
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of
Joshi T; Joshi T; Sharma P; Chandra S; Pande V
J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918
[No Abstract] [Full Text] [Related]
8. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential inhibitors against
Gaur V; Kumar N; Vyas A; Chowdhury D; Singh J; Bera S
J Biomol Struct Dyn; 2023 Dec; ():1-11. PubMed ID: 38149858
[TBL] [Abstract][Full Text] [Related]
10. Caffeic acid phenethyl ester (CAPE), an active component of propolis, inhibits Helicobacter pylori peptide deformylase activity.
Cui K; Lu W; Zhu L; Shen X; Huang J
Biochem Biophys Res Commun; 2013 May; 435(2):289-94. PubMed ID: 23611786
[TBL] [Abstract][Full Text] [Related]
11. Structural modelling and
Ayipo YO; Alananzeh WA; Ahmad I; Patel H; Mordi MN
J Biomol Struct Dyn; 2023; 41(13):6219-6235. PubMed ID: 35881145
[TBL] [Abstract][Full Text] [Related]
12. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Jana S; Singh SK
J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
[TBL] [Abstract][Full Text] [Related]
13. In silico identification of potential Hsp90 inhibitors via ensemble docking, DFT and molecular dynamics simulations.
Rezvani S; Ebadi A; Razzaghi-Asl N
J Biomol Struct Dyn; 2022; 40(21):10665-10676. PubMed ID: 34286666
[TBL] [Abstract][Full Text] [Related]
14. In silico probing exercises, bioactive-conformational and dynamic simulations strategies for designing and promoting selective therapeutics against Helicobacter pylori strains.
Pasala C; Katari SK; Nalamolu RM; Bitla AR; Amineni U
J Mol Graph Model; 2019 Nov; 92():167-179. PubMed ID: 31376734
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure activity relationship and molecular simulations for the exploration of natural potent VEGFR-2 inhibitors: an
Sharma N; Sharma M; Rahman QI; Akhtar S; Muddassir M
J Biomol Struct Dyn; 2021 May; 39(8):2806-2823. PubMed ID: 32363995
[TBL] [Abstract][Full Text] [Related]
16. Computational identification of new TKI as potential noncovalent reversible EGFR
Abdelmalek D; Smaoui F; Frikha F; Ben Marzoug R; Msalbi D; Souissi A; Aifa MS
J Biomol Struct Dyn; 2024 Jun; 42(9):4870-4887. PubMed ID: 37349947
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
[TBL] [Abstract][Full Text] [Related]
18. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
Mandal RS; Das S
J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
[TBL] [Abstract][Full Text] [Related]
19. Structure prediction and discovery of inhibitors against phosphopantothenoyl cysteine synthetase of
Gupta A; Vijayan V; Pant P; Kaur P; Singh TP; Sharma P; Sharma S
J Biomol Struct Dyn; 2022; 40(21):11405-11417. PubMed ID: 34348086
[No Abstract] [Full Text] [Related]
20. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
